The Regulatory Domain within the Healthcare Innovation Cycle

An innovative XR solution may have the potential to transform healthcare, but technological excellence alone is not enough. Understanding regulatory requirements is essential to bringing healthcare innovations safely and responsibly to market. Within VR Health Champions, the Regulatory domain of the Healthcare Innovation Cycle supports four flagship SMEs – MEEVA, MedApp S.A., MetaSkills and dotLumen – in navigating regulatory challenges, strengthening their readiness and making informed development decisions.

Every healthcare innovation begins with an ambition to make something better.A new technology may help clinicians perform complex procedures, support rehabilitation, improve accessibility or create more realistic training environments. Yet translating this potential into real-world healthcare applications brings responsibilities that extend beyond technological performance. Innovators must understand which regulatory requirements apply to their solutions, what evidence may be needed and how to demonstrate compliance.

For emerging companies, these questions are rarely straightforward. They require specialist knowledge, careful planning and an understanding of how regulatory decisions can influence product development.

This is where the Regulatory domain of the Healthcare Innovation Cycle comes into focus. Drawing on the Healthcare Innovation Cycle as a conceptual framework, VR Health Champions connects regulatory expertise with the practical challenges faced by healthcare innovators.

“For many healthcare startups, regulatory requirements can seem overwhelming. Our role is to help innovators understand what applies to their solutions, identify the steps they need to take and make informed decisions throughout the development process. Regulatory readiness is not simply about documentation. It is about building safer and more reliable healthcare technologies.” – Cristiana Costa, Instituto Pedro Nunes (IPN)



Understanding the rules behind healthcare innovation

Developing technology for healthcare means entering one of Europe’s most closely regulated environments. Under the European Union’s Medical Device Regulation (MDR), medical devices are subject to requirements that depend on factors such as their intended purpose and risk classification. These requirements influence the evidence, documentation and conformity assessment procedures needed before a device can be placed on the European market. For companies developing XR technologies, the regulatory picture can be particularly complex.

An immersive training platform, an assistive technology or an augmented reality solution supporting medical procedures may serve very different purposes. Their regulatory obligations therefore cannot be assumed to be identical. The intended purpose of a product is fundamental to determining which regulatory requirements apply.

Understanding these differences is particularly important for emerging companies, where development teams may have extensive technological expertise but limited experience navigating medical device regulations. Within VR Health Champions, the Regulatory domain addresses this challenge through individual regulatory assistance tailored to the needs of each flagship SME. Rather than offering a single approach for every innovation, the project recognises that each solution has its own characteristics, development priorities and regulatory considerations.



From uncertainty to informed decisions

For a start-up developing an innovative healthcare solution, regulatory requirements can sometimes feel like a complicated set of rules standing between an idea and its potential users. But understanding those requirements can also help innovators make better decisions about their products. Within VR Health Champions, regulatory support begins with an assessment of the specific needs and regulatory maturity of each flagship SME. This assessment helps identify potential gaps, clarify applicable requirements and establish priorities for further development.

Based on the findings, startups receive one-on-one advisory and mentoring support addressing regulatory processes associated with the medical device lifecycle. The assistance may involve understanding relevant MDR requirements, identifying documentation needs, reviewing regulatory considerations or preparing for activities that support future conformity assessment. Importantly, the support is adapted to the individual circumstances of each company.

For some innovators, the priority may be understanding how their solution should be classified. For others, it may involve strengthening regulatory documentation or identifying additional evidence needed to support compliance. The objective is not to impose identical requirements on different technologies, but to help each startup navigate its own regulatory challenges.



Regulatory readiness is built through collaboration

Regulatory compliance does not exist in isolation from technological development or clinical evaluation.

A decision made during product development may influence regulatory documentation. Evidence gathered through verification and validation may help demonstrate that a solution meets relevant requirements. Regulatory considerations, in turn, may inform how a product is designed, tested and refined. This relationship reflects an important principle of the Healthcare Innovation Cycle: progress across the Technology, Clinical, Regulatory and Market/Business domains takes place in parallel, with activities contributing to more than one domain. Within VR Health Champions, regulatory advisory services complement the work carried out across other project activities.

As flagship SMEs refine their technologies and engage in verification and validation, regulatory experts help them understand how relevant findings and development decisions relate to their compliance obligations. This collaborative approach encourages innovators to consider regulatory requirements throughout product development rather than treating them as a separate concern. It also brings together different perspectives.

Technology developers understand how their solutions work. Clinical experts contribute knowledge of healthcare environments and patient needs. Regulatory specialists help interpret applicable requirements and identify the evidence and documentation necessary to demonstrate compliance. Together, these perspectives support more informed and responsible innovation.

“Regulatory readiness develops alongside technological and clinical progress. When developers, clinical experts and regulatory specialists exchange knowledge, it becomes easier to identify requirements early, address potential challenges and build the evidence needed to support future conformity assessment.”- András Perényi, Spherical Research Institute (SRI)



Four innovations, different regulatory considerations

The four flagship SMEs participating in VR Health Champions demonstrate how different healthcare technologies raise different regulatory questions.

MedApp develops advanced medical visualisation and navigation technologies designed to support healthcare professionals during complex medical procedures. MEEVA focuses on immersive autism solutions, while dotLumen develops assistive technology to help people with visual impairments navigate their surroundings more independently. MetaSkills, meanwhile, creates immersive XR training environments that allow healthcare professionals to develop practical skills through realistic simulations.

Although these innovations share an ambition to improve healthcare, their intended purposes and technical characteristics differ. So do the regulatory questions their developers need to address.

For some, the challenge may involve medical device classification and compliance requirements. For others, demonstrating quality, reliability or suitability for a particular healthcare application may involve different forms of assessment. Understanding these distinctions helps innovators identify the requirements relevant to their solutions and make better-informed development decisions.

“Developing an innovative healthcare technology involves much more than making the product work. Understanding the regulatory requirements helps us see what evidence and documentation may be needed and how these considerations should influence our development decisions. Having access to specialised expertise makes that process easier to navigate.” – Maciej Stanuch, MedApp S.A.



More than a regulatory checklist

For many innovators, CE marking represents an important milestone in bringing a medical device to the European market. However, preparing for conformity assessment involves considerably more than completing a checklist. Depending on the product and its regulatory classification, manufacturers may need to demonstrate compliance through technical documentation, risk management, appropriate evaluation activities and other applicable requirements. These obligations can require substantial expertise, resources and careful planning.

For smaller companies, navigating this process without specialist assistance can be particularly challenging. VR Health Champions addresses this challenge by supporting flagship SMEs in strengthening their regulatory maturity. The objective is to help innovators become better prepared for the regulatory processes relevant to their technologies, rather than suggesting that certification can be achieved through a single activity or consultation. Regulatory compliance is not the only area in which healthcare innovators must demonstrate that their solutions meet defined standards. Depending on the nature of the innovation, external evaluation and quality assurance may also play an important role in building credibility and trust. One example comes from MetaSkills, a VR Health Champions flagship SME that recently achieved an important milestone through a process supported by project partner InnoStars (INN).

In October 2026, MetaSkills received the EIT Label for Non-Degree Education and Training for its Digital Health Conversations for Healthcare Teams & Professionals: An AI Simulation-Based Training Course. The accreditation followed a process that began in autumn 2025 and was coordinated in collaboration with Instituto Pedro Nunes (IPN), a partner in VR Health Champions.

During this period, MetaSkills developed the training programme, defined its learning objectives, prepared AI-powered conversation scenarios and established methods for assessing participants’ competencies.

The programme and its supporting documentation were subsequently evaluated by external EIT Health experts, who assessed the coherence of its educational approach, teaching and assessment methods, and quality assurance procedures. The EIT Label confirms that the programme meets specified educational quality standards.

Although distinct from medical device certification, the EIT Label demonstrates how independent evaluation can recognise the educational quality of an innovative healthcare training programme.

“We want to give healthcare professionals a safe space to practise conversations with patients and colleagues. AI allows them to explore different approaches, receive specific feedback and try again. The EIT Label is an important recognition of the educational quality of our programme, and achieving it demonstrates the value of collaborating with our VR Health Champions partners.” – Kuba Pędziwiatr, Metaskills



Innovation carries responsibility

Behind every healthcare technology are people who may one day rely on it – patients, healthcare professionals and those responsible for delivering care. For innovators, understanding regulatory requirements is therefore about more than preparing documentation or navigating complex procedures. It is about making informed decisions that help build confidence in the technologies they develop.

Through individual assessments, specialist advice and collaboration across the Healthcare Innovation Cycle, VR Health Champions helps its flagship SMEs address these responsibilities as their solutions evolve. Because in healthcare, innovation is not measured by what technology can do alone, but also by the confidence we can place in it.

Comments